{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:02:06Z","timestamp":1761166926996,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jocd.2020.05.010","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T11:59:23Z","timestamp":1591099163000},"page":"362-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association Between FGF-23 Levels and Risk of Fracture in Women With Systemic Sclerosis"],"prefix":"10.1016","volume":"24","author":[{"given":"Lucia","family":"Cantero-Nieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-193X","authenticated-orcid":false,"given":"Antonio","family":"\u00c1lvarez-Cienfuegos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Alberto","family":"Garc\u00eda-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"R\u00edos-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2325-0937","authenticated-orcid":false,"given":"Norberto","family":"Ortego-Centeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jocd.2020.05.010_bib0001","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, bubsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.jocd.2020.05.010_bib0002","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.semarthrit.2004.08.006","article-title":"Osteoporosis in scleroderma","volume":"34","author":"Loucks","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jocd.2020.05.010_bib0003","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.physiol.69.040705.141729","article-title":"Phosphatonins and the regulation of phosphate homeostasis","volume":"69","author":"Berndt","year":"2007","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"10.1016\/j.jocd.2020.05.010_bib0004","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphonate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jocd.2020.05.010_bib0005","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jbmr.263","article-title":"Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men","volume":"26","author":"Mirza","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jocd.2020.05.010_bib0006","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.jocd.2020.05.010_bib0007","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jocd.2011.05.007","article-title":"Joint official positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX. Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX in Clinical Practice","volume":"14","author":"Hans","year":"2011","journal-title":"J Clin Densitom"},{"issue":"11","key":"10.1016\/j.jocd.2020.05.010_bib0008","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"Van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jocd.2020.05.010_bib0009","unstructured":"National Kidney Foundation. 2002 K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1-266."},{"issue":"10","key":"10.1016\/j.jocd.2020.05.010_bib0010","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.jocd.2020.05.010_bib0011","first-page":"1073","article-title":"Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions","volume":"35","author":"Yuen","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocd.2020.05.010_bib0012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/OARRR.S29000","article-title":"A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology","volume":"4","author":"Tanner","year":"2012","journal-title":"Open Access Rheumatol"},{"issue":"6","key":"10.1016\/j.jocd.2020.05.010_bib0013","article-title":"Vitamin D deficiency in a cohort of patients with systemic scleroderma from the south of Spain","volume":"37","author":"Rios Fernandez","year":"2010","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.jocd.2020.05.010_bib0014","first-page":"905","article-title":"Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions","volume":"30","author":"Rios-Fernandez","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.jocd.2020.05.010_bib0015","doi-asserted-by":"crossref","first-page":"e66991","DOI":"10.1371\/journal.pone.0066991","article-title":"Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study","volume":"8","author":"Atteritano","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jocd.2020.05.010_bib0016","first-page":"313","article-title":"Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis","volume":"22","author":"Frediani","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.jocd.2020.05.010_bib0017","first-page":"1822","article-title":"Osteoporosis \u2013 less than expected in patients with scleroderma?","volume":"27","author":"Neumann","year":"2000","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.jocd.2020.05.010_bib0018","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02207673","article-title":"Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis","volume":"14","author":"Di Munno","year":"1995","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.jocd.2020.05.010_bib0019","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/03009740600704296","article-title":"Systemic sclerosis and bone loss: the role of the disease and body composition","volume":"35","author":"Souza","year":"2006","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.jocd.2020.05.010_bib0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/rheumatology\/kes240","article-title":"Prevalence and risk factors of low bone mineral density in Chinese patients with systemic sclerosis: a case-control study","volume":"52","author":"Mok","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.jocd.2020.05.010_bib0021","first-page":"180","article-title":"Prognostic factors of low bone mineral density in systemic sclerosis","volume":"23","author":"Sampaio-Barros","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.jocd.2020.05.010_bib0022","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13075-019-2072-y","article-title":"Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients","volume":"21","author":"Horv\u00e1th","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"7-8","key":"10.1016\/j.jocd.2020.05.010_bib0023","first-page":"535","article-title":"Bone mineral density and bone turnover in systemic sclerosis","volume":"93","author":"Alexandersson","year":"2007","journal-title":"Laeknabladid"},{"issue":"2","key":"10.1016\/j.jocd.2020.05.010_bib0024","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.jocd.2020.05.010_bib0025","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tem.2012.07.002","article-title":"Fibroblast growth factor 23: state of the field and future directions","volume":"23","author":"Bhattacharyya","year":"2012","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jocd.2020.05.010_bib0026","first-page":"530","article-title":"FGF-23, Klotho and Vitamin D levels in Scleroderma","volume":"46","author":"Ahmadi","year":"2017","journal-title":"Iran J Public Health"},{"issue":"2","key":"10.1016\/j.jocd.2020.05.010_bib0027","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejr.2014.12.007","article-title":"Fibroblast growth factor-23 in patients with systemic sclerosis: A case\u2013control study","volume":"38","author":"Shenavandeh","year":"2015","journal-title":"The Egyptian Rheumatologist"},{"issue":"9","key":"10.1016\/j.jocd.2020.05.010_bib0028","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1007\/s00198-017-4104-2","article-title":"Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults","volume":"28","author":"Coulson","year":"2017","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.jocd.2020.05.010_bib0029","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jbmr.2750","article-title":"Associations of FGF23 with change in bone mineral density and fracture risk in older individuals","volume":"31","author":"Isakova","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jocd.2020.05.010_bib0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical Practice. Postmenopausal Osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jocd.2020.05.010_bib0031","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","article-title":"The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women","volume":"18","author":"Kanis","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2020.05.010_bib0032","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2369-13-122","article-title":"Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients","volume":"13","author":"Kanda","year":"2012","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.jocd.2020.05.010_bib0033","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.3390\/diagnostics10030145","article-title":"A review of the potential application of osteocyte-related biomarkers, fibroblast growth factor-23, sclerostin, and dickkopf-1 in predicting osteoporosis and fractures","volume":"10","author":"Ramli","year":"2020","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.jocd.2020.05.010_bib0034","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2011.06.011","article-title":"Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study","volume":"58","author":"Ix","year":"2011","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695020300913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695020300913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:44:03Z","timestamp":1761083043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695020300913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1094695020300913"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2020.05.010","relation":{},"ISSN":["1094-6950"],"issn-type":[{"type":"print","value":"1094-6950"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between FGF-23 Levels and Risk of Fracture in Women With Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2020.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The International Society for Clinical Densitometry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}